Comparative Pharmacology
Head-to-head clinical analysis: FALLBACK SOLO versus PREVEN EMERGENCY CONTRACEPTIVE KIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FALLBACK SOLO versus PREVEN EMERGENCY CONTRACEPTIVE KIT.
FALLBACK SOLO vs PREVEN EMERGENCY CONTRACEPTIVE KIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FALLBACK SOLO is a small molecule inhibitor of the Hedgehog signaling pathway. It binds to and inhibits Smoothened (SMO), a transmembrane protein that activates the GLI transcription factors. This inhibition blocks the aberrant activation of the Hedgehog pathway, which is implicated in the growth of certain cancers.
The levonorgestrel component is a progestin that inhibits ovulation and fertilization by altering the cervical mucus and endometrial lining, preventing implantation. The ethinyl estradiol component suppresses gonadotropin release, inhibits ovulation, and alters the endometrium.
100 mg orally once daily
The kit contains levonorgestrel 0.75 mg tablets. The regimen is two tablets: one tablet taken orally as soon as possible within 72 hours of unprotected intercourse, followed by a second tablet taken orally 12 hours later.
None Documented
None Documented
Terminal half-life: 12 hours (range 10–14 h); clinical context: once-daily dosing achieves steady state in 2.5 days
26 hours (range 17-35 hours; clinical: no significant accumulation with single dose).
Renal: 80% unchanged; fecal: 15% as metabolites; biliary: 5%
Primarily renal (50-60% as metabolites, <1% unchanged) and fecal (30-40% as metabolites).
Category C
Category C
Emergency Contraceptive
Emergency Contraceptive